CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
![medical analytics, digital AI interface, DNA insights, machine learning, healthcare-GettyImages-2262212754]( "Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials")
Predictive Analytics Is Reshaping How Sponsors Run Clinical TrialsPredictive analytics is transforming clinical trial operations, from enrollment forecasting to risk-based monitoring. Here’s what sponsors need to know.
-
![Edge computing 873875560]( "Edge AI Is Reshaping How Clinical Trials Run")
Edge AI Is Reshaping How Clinical Trials RunEdge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.
ECOA RESOURCES
-
![GettyImages-2183708450-doctor-with-patient-tablet-doctors-office]( "Navigating eCOA Licensing And Localization In Clinical Trials")
eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.
-
![Mobile Device Management]( "Beyond The Pandemic: Why eCOAs Are Here To Stay")
The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.
-
![IQVIA eCOA Sculptor Portal]( "Real-Time Data Tracking And Compliance Monitoring")
Unlock real-time data tracking, customizable reporting, and proactive compliance monitoring with the IQVIA eCOA Sculptor Portal to enhance clinical decision-making and ensure protocol adherence.
ECONSENT RESOURCES
-
![GettyImages-1496098113_patient phone]( "Using eConsent Data To Populate Site And Sponsor Data Systems")
A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.
-
![GettyImages-1648451225 Scientist holding tray of samples in laboratory]( "Introducing Digitally-Enabled Biosample Consent Storage")
Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.
-
![Designing ePRO and eConsent Solutions that Participants and Sites Want]( "Designing ePRO and eConsent Solutions that Participants and Sites Want")
Participant-focused eClinical technologies offer significant potential to decrease paper-based processes and improve end-user experiences in collecting patient-reported outcomes (PRO) and informed consent, but many users continue to experience rigid technology, complicated hardware provisioning processes, and clunky implementations that leave sponsors, CROs and sites questioning the value.
EPRO RESOURCES
-
![Designing ePRO and eConsent Solutions that Participants and Sites Want]( "Designing ePRO and eConsent Solutions that Participants and Sites Want")
Participant-focused eClinical technologies offer significant potential to decrease paper-based processes and improve end-user experiences in collecting patient-reported outcomes (PRO) and informed consent, but many users continue to experience rigid technology, complicated hardware provisioning processes, and clunky implementations that leave sponsors, CROs and sites questioning the value.
-
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
-
![The impact of ePRO on the patient & site journeys]( "ePRO's Impact On Patient And Site Journeys")
Join our solutions experts as they demonstrate how Castor ePRO can enhance your clinical trial by improving the patient experience and streamlining site operations.
